North Chicago, IL, United States of America

Carl M Knable



 

Average Co-Inventor Count = 11.1

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Elmhurst, IL (US) (2016 - 2018)
  • North Chicago, IL (US) (2017 - 2020)

Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Carl M. Knable

Introduction

Carl M. Knable is a prolific inventor based in North Chicago, IL, renowned for his significant contributions to the pharmaceutical industry. With a total of six patents under his name, Knable has demonstrated a commitment to advancing drug formulations, particularly in the realm of high-purity substances.

Latest Patents

His latest patents include the development of high purity oritavancin and methods for producing this novel compound. These inventions detail drug substance preparations of oritavancin characterized by high purity, along with pharmaceutical compositions that encompass these preparations. Additionally, he has explored the creation of drug products or dosage forms that utilize these innovative pharmaceutical compositions, thus potentially benefiting patients with improved treatment options.

Career Highlights

Carl M. Knable has made significant strides in his career, having worked with notable organizations such as AbbVie Inc. and Melinta Therapeutics, Inc. His tenure at these companies has allowed him to leverage his expertise in drug development and contribute positively to the field of medicinal chemistry.

Collaborations

In his quest for innovation, Knable has collaborated with fellow professionals, including Jonathan Mark Miller and John B. Morris. These partnerships illustrate his ability to work synergistically with other experts in pharmaceutical sciences, fostering an environment of creativity and technological advancement.

Conclusion

In conclusion, Carl M. Knable exemplifies the spirit of innovation within the pharmaceutical industry through his dedicated efforts and impressive patent portfolio. His groundbreaking work on high purity oritavancin showcases his commitment to improving drug formulations and patient care. As he continues to push the boundaries of pharmaceutical research, Knable remains a notable figure in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…